Kikushige et al. showed that TIM-3+ but not TIM-3− AML cells were able to form tumor in vivo, suggesting that TIM-3+ subset contains the majority of functional CSC population [285]. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.